PFIC
Mirum Pharmaceuticals publishes phase 3 MARCH maralixibat data in The Lancet
May 8, 2024Research and Development Hepatology, Mirum Pharmaceuticals, PFIC, The Lancet, clinical trials
Biopharma company Mirum Pharmaceuticals has announced data from its phase 3 MARCH-PFIC study which evaluated maralixibat in patients with progressive …
